1.23
5.38%
-0.07
Vorhandelsmarkt:
1.27
0.04
+3.25%
Finanzdaten der An 2 Therapeutics Inc-Aktie (ANTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.76%
18.30
|
18.82 | 18.18 | 16.60 | 16.04 |
Operating Income/Loss |
2.76%
-18.30
|
-18.82 | -18.18 | -16.60 | -16.04 |
Income/Loss From Continuing Operations Before Tax |
1.66%
-16.62
|
-16.90 | -16.71 | -15.80 | -15.32 |
Income/Loss From Continuing Operations After Tax |
1.66%
-16.62
|
-16.90 | -16.71 | -15.80 | -15.32 |
Net Income/Loss
|
1.66%
-16.62
|
-16.90 | -16.71 | -15.80 | -15.32 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,340%
29.76
|
2.0676 | 25.65 | 19.50 | 19.39 |
Diluted Average Shares |
1,340%
29.76
|
2.0676 | 25.65 | 19.50 | 19.39 |
Basic Earnings Per Share |
7.69%
-0.56
|
-0.52 | -0.65 | -0.81 | -0.79 |
Diluted Earnings Per Share |
7.69%
-0.56
|
-0.52 | -0.65 | -0.81 | -0.79 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):